216 related articles for article (PubMed ID: 30854581)
1. Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.
Li S; Peng F; Gong W; Wu J; Wang Y; Xu Z; Liu W; Li H; Yin B; Zhang Y; Chen S; Luo C; Li P; Chen Y; Huang Q; Zhou W; Long H
J Mol Med (Berl); 2019 May; 97(5):659-674. PubMed ID: 30854581
[TBL] [Abstract][Full Text] [Related]
2. Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis.
Li S; Luo C; Chen S; Zhuang Y; Ji Y; Zeng Y; Zeng Y; He X; Xiao J; Wang H; Chen X; Long H; Peng F
J Transl Med; 2023 Sep; 21(1):639. PubMed ID: 37726857
[TBL] [Abstract][Full Text] [Related]
3. Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway.
Peng F; Li H; Li S; Wang Y; Liu W; Gong W; Yin B; Chen S; Zhang Y; Luo C; Zhou W; Chen Y; Li P; Huang Q; Xu Z; Long H
Lab Invest; 2019 Jul; 99(8):1092-1106. PubMed ID: 30976056
[TBL] [Abstract][Full Text] [Related]
4. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
5. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
6. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
7. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Bai Y; Wang L; TingYang ; Wang L; Ge W
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2379-2391. PubMed ID: 37052642
[TBL] [Abstract][Full Text] [Related]
8. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
11. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
[TBL] [Abstract][Full Text] [Related]
12. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.
Liu W; Chen X; Wang Y; Chen Y; Chen S; Gong W; Chen T; Sun L; Zheng C; Yin B; Li S; Luo C; Huang Q; Xiao J; Xu Z; Peng F; Long H
Pharmacol Res; 2019 Dec; 150():104506. PubMed ID: 31669149
[TBL] [Abstract][Full Text] [Related]
13. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
15. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
17. Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo.
An Y; Guo W; Li L; Xu C; Yang D; Wang S; Lu Y; Zhang Q; Zhai J; Fan H; Qiu C; Qi J; Chen Y; Yuan S
PLoS One; 2015; 10(2):e0116202. PubMed ID: 25658946
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis.
Shi Y; Hu Y; Wang Y; Ma X; Tang L; Tao M; Qiu A; Zhuang S; Liu N
Front Pharmacol; 2021; 12():724141. PubMed ID: 34497522
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model.
Yoshimine H; Tanoue S; Ibi Y; Minami M; Nakahara M; Tokunaga K; Kanmura S; Ido A
Clin Exp Nephrol; 2021 Sep; 25(9):935-943. PubMed ID: 33909175
[TBL] [Abstract][Full Text] [Related]
20. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q
Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
